Dechra Pharmaceuticals Plc (DPH.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2018 | 06-2017 | 06-2016 | 06-2015 | 06-2014 | |
| Cash Flows From Operating Activities | |||||
| Income taxes - deferred | N/A | N/A | 2,036 | 6,347 | 2,322 |
| Accounts receivable | -9,500 | 6,360 | -16,393 | -2,553 | -21,100 |
| Other Working Capital | -23,400 | 6,930 | 5,354 | -2,342 | -25,070 |
| Other Operating Activity | 96,900 | 64,136 | 52,578 | 39,531 | 55,320 |
| Operating Cash Flow | $64,000 | $77,426 | $43,575 | $40,983 | $11,472 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,900 | -4,221 | -2,802 | -2,081 | -4,927 |
| Net Acquisitions | -229,100 | -46,562 | -166,563 | -908 | 83,688 |
| Purchase Sale Intangibles | -6,400 | -5,266 | -4,133 | -643 | -1,381 |
| Other Investing Activity | -1,300 | -1,226 | -537 | -1,019 | -805 |
| Investing Cash Flow | $-241,700 | $-57,275 | $-174,035 | $-4,651 | $76,575 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 133,400 | 25,000 | 103,841 | 0 | 1,558 |
| Debt Repayment | -17,200 | -5,879 | -10,572 | -102 | -81,470 |
| Common Stock Issued | 103,300 | 930 | 47,697 | 375 | 949 |
| Common Stock Repurchased | 0 | -646 | N/A | 0 | -606 |
| Dividend Paid | -21,800 | -17,664 | -15,292 | -13,857 | -12,579 |
| Other Financing Activity | -3,900 | -150 | -360 | -1,235 | 0 |
| Financing Cash Flow | $193,800 | $1,591 | $125,314 | $-14,819 | $-92,148 |
| Exchange Rate Effect | 2,400 | 316 | -1,660 | -2,338 | -1,917 |
| Beginning Cash Position | 61,200 | 39,142 | 45,948 | 26,773 | 32,791 |
| End Cash Position | 79,700 | 61,200 | 39,142 | 45,948 | 26,773 |
| Net Cash Flow | $16,100 | $21,742 | $-5,146 | $21,513 | $-4,101 |
| Free Cash Flow | |||||
| Operating Cash Flow | 64,000 | 77,426 | 43,575 | 40,983 | 11,472 |
| Capital Expenditure | -12,600 | -10,745 | -7,505 | -3,759 | -7,373 |
| Free Cash Flow | 51,400 | 66,681 | 36,070 | 37,224 | 4,099 |